ArticleBMC musculoskeletal disorders2026
Clinical outcomes of using 4 + 5 extensor compartment pedicled vascularized bone graft in Kienböck's disease.
Article in BMC musculoskeletal disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to evaluate the mid-term clinical and radiological outcomes of a 4th-5th extensor compartment artery (4 + 5 ECA) pedicled vascularized distal radius bone graft in patients with Lichtman stage II and IIIa Kienböck's disease, with a particular focus on differences between disease stages and magnetic resonance imaging (MRI) evidence of lunate revascularization.
methodsA retrospective review was conducted on 30 patients (31 wrists) treated with a 4 + 5 ECA pedicled vascularized bone graft between 2022 and 2024. Nineteen wrists were classified as Lichtman stage II and 12 as stage IIIa. Clinical evaluation included visual analog scale (VAS) pain score, Mayo Wrist Score, wrist range of motion, and grip strength. Radiological assessment comprised plain radiographs and MRI, evaluating Lichtman stage progression, carpal height ratio, Stahl index, and MRI signal changes suggestive of revascularization. Preoperative and final follow-up results were compared within and between stage subgroups.
resultsThe mean follow-up duration was 27.5 months. In the entire cohort, VAS pain scores significantly decreased (6.1 to 2.6) and Mayo Wrist Scores significantly improved (36.4 to 68.4) (p < 0.05). Grip strength increased from 55.2% to 70.6% of the contralateral side. Clinical improvements were significantly greater in stage II patients than in stage IIIa patients. MRI findings consistent with lunate revascularization were observed in 21.1% of stage II wrists, whereas no clear revascularization was detected in stage IIIa wrists. Disease progression occurred in 29.0% of all cases, more frequently in stage IIIa wrists.
conclusionsThe 4 + 5 ECA pedicled vascularized bone graft is a safe and effective treatment for early-stage Kienböck's disease, providing significant pain relief and functional improvement. Clinical and radiological outcomes are more favorable in Lichtman stage II patients, supporting early surgical intervention with appropriate indications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.